Invus, Wexford Capital and HBM-MedFocus led a $18m Series B round in Viseon.

Investment firm Invus, Wexford Capital and HBM-MedFocus led a $18m Series B round in Viseon, a privately held medical device company. "We are very pleased to have the ongoing support from our current investment partners, with confidence underscored by inside-only investor participation and oversubscription. Ongoing advancements in minimally invasive surgical techniques often bring the consequence, and risk of limited visualization. As fundamental as it may seem, enhanced real-time intraoperative visualization projected onto a large high-definition flat panel display will contribute toward clinical outcomes improvement, procedural efficiency, reduced risk of complications, OR staff involvement teaching opportunity and procedure expansion," Jeffrey Valko, Viseon President and CEO.